(8E)-16-bromo-15-fluoro-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,8,13,15,17,21,23-nonaen-19-one;(9Z)-15-fluoro-16-(5-methyl-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-3-yl)-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13(18),14,16,21,23-nonaen-19-one;(9Z)-15-fluoro-16-morpholin-4-yl-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13,15,17,21,23-nonaen-19-one;(8E)-15-fluoro-16-(1-propylpyrazol-4-yl)-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,8,13(18),14,16,21,23-nonaen-19-one;(9Z)-15-fluoro-16-(1-propylpyrazol-4-yl)-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13(18),14,16,21,23-nonaen-19-one;(9Z)-15-fluoro-16-pyridin-4-yl-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13(18),14,16,21,23-nonaen-19-one

C148H136BrF6N33O13 — CID 158716369

About (8E)-16-bromo-15-fluoro-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,8,13,15,17,21,23-nonaen-19-one;(9Z)-15-fluoro-16-(5-methyl-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-3-yl)-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13(18),14,16,21,23-nonaen-19-one;(9Z)-15-fluoro-16-morpholin-4-yl-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13,15,17,21,23-nonaen-19-one;(8E)-15-fluoro-16-(1-propylpyrazol-4-yl)-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,8,13(18),14,16,21,23-nonaen-19-one;(9Z)-15-fluoro-16-(1-propylpyrazol-4-yl)-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13(18),14,16,21,23-nonaen-19-one;(9Z)-15-fluoro-16-pyridin-4-yl-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13(18),14,16,21,23-nonaen-19-one

(8E)-16-bromo-15-fluoro-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,8,13,15,17,21,23-nonaen-19-one;(9Z)-15-fluoro-16-(5-methyl-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-3-yl)-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13(18),14,16,21,23-nonaen-19-one;(9Z)-15-fluoro-16-morpholin-4-yl-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13,15,17,21,23-nonaen-19-one;(8E)-15-fluoro-16-(1-propylpyrazol-4-yl)-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,8,13(18),14,16,21,23-nonaen-19-one;(9Z)-15-fluoro-16-(1-propylpyrazol-4-yl)-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13(18),14,16,21,23-nonaen-19-one;(9Z)-15-fluoro-16-pyridin-4-yl-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13(18),14,16,21,23-nonaen-19-one (PubChem CID 158716369) has the molecular formula C148H136BrF6N33O13 and a molecular weight of 2778.83 g/mol. Its IUPAC name is (8E)-16-bromo-15-fluoro-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,8,13,15,17,21,23-nonaen-19-one;(9Z)-15-fluoro-16-(5-methyl-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-3-yl)-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13(18),14,16,21,23-nonaen-19-one;(9Z)-15-fluoro-16-morpholin-4-yl-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13,15,17,21,23-nonaen-19-one;(8E)-15-fluoro-16-(1-propylpyrazol-4-yl)-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,8,13(18),14,16,21,23-nonaen-19-one;(9Z)-15-fluoro-16-(1-propylpyrazol-4-yl)-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13(18),14,16,21,23-nonaen-19-one;(9Z)-15-fluoro-16-pyridin-4-yl-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13(18),14,16,21,23-nonaen-19-one.

Molecular Properties

• Compound Name: (8E)-16-bromo-15-fluoro-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,8,13,15,17,21,23-nonaen-19-one;(9Z)-15-fluoro-16-(5-methyl-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-3-yl)-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13(18),14,16,21,23-nonaen-19-one;(9Z)-15-fluoro-16-morpholin-4-yl-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13,15,17,21,23-nonaen-19-one;(8E)-15-fluoro-16-(1-propylpyrazol-4-yl)-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,8,13(18),14,16,21,23-nonaen-19-one;(9Z)-15-fluoro-16-(1-propylpyrazol-4-yl)-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13(18),14,16,21,23-nonaen-19-one;(9Z)-15-fluoro-16-pyridin-4-yl-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13(18),14,16,21,23-nonaen-19-one
• PubChem CID: 158716369
• Molecular Formula: C148H136BrF6N33O13
• Molecular Weight: 2778.83 g/mol
• Exact Mass: 2776.01
• IUPAC Name: (8E)-16-bromo-15-fluoro-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,8,13,15,17,21,23-nonaen-19-one;(9Z)-15-fluoro-16-(5-methyl-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-3-yl)-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13(18),14,16,21,23-nonaen-19-one;(9Z)-15-fluoro-16-morpholin-4-yl-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13,15,17,21,23-nonaen-19-one;(8E)-15-fluoro-16-(1-propylpyrazol-4-yl)-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,8,13(18),14,16,21,23-nonaen-19-one;(9Z)-15-fluoro-16-(1-propylpyrazol-4-yl)-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13(18),14,16,21,23-nonaen-19-one;(9Z)-15-fluoro-16-pyridin-4-yl-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13(18),14,16,21,23-nonaen-19-one
• SMILES: CCCn1cc(-c2cc3c(cc2F)OC/C=C\CCn2ccnc2-c2cccc(n2)NC3=O)cn1.CCCn1cc(-c2cc3c(cc2F)OCC/C=C/Cn2ccnc2-c2cccc(n2)NC3=O)cn1.CN1CCn2ncc(-c3cc4c(cc3F)OC/C=C\CCn3ccnc3-c3cccc(n3)NC4=O)c2C1.O=C1Nc2cccc(n2)-c2nccn2C/C=C/CCOc2cc(F)c(Br)cc21.O=C1Nc2cccc(n2)-c2nccn2CC/C=C\COc2cc(F)c(-c3ccncc3)cc21.O=C1Nc2cccc(n2)-c2nccn2CC/C=C\COc2cc(F)c(N3CCOCC3)cc21
• InChI: InChI=1S/C27H26FN7O2.2C26H25FN6O2.C25H20FN5O2.C24H24FN5O3.C20H16BrFN4O2/c1-33-11-12-35-23(17-33)20(16-30-35)18-14-19-24(15-21(18)28)37-13-4-2-3-9-34-10-8-29-26(34)22-6-5-7-25(31-22)32-27(19)36;2*1-2-10-33-17-18(16-29-33)19-14-20-23(15-21(19)27)35-13-5-3-4-11-32-12-9-28-25(32)22-7-6-8-24(30-22)31-26(20)34;26-20-16-22-19(15-18(20)17-7-9-27-10-8-17)25(32)30-23-6-4-5-21(29-23)24-28-11-13-31(24)12-2-1-3-14-33-22;25-18-16-21-17(15-20(18)29-10-13-32-14-11-29)24(31)28-22-6-4-5-19(27-22)23-26-7-9-30(23)8-2-1-3-12-33-21;21-14-11-13-17(12-15(14)22)28-10-3-1-2-8-26-9-7-23-19(26)16-5-4-6-18(24-16)25-20(13)27/h2,4-8,10,14-16H,3,9,11-13,17H2,1H3,(H,31,32,36);3,5-9,12,14-17H,2,4,10-11,13H2,1H3,(H,30,31,34);3-4,6-9,12,14-17H,2,5,10-11,13H2,1H3,(H,30,31,34);1,3-11,13,15-16H,2,12,14H2,(H,29,30,32);1,3-7,9,15-16H,2,8,10-14H2,(H,27,28,31);1-2,4-7,9,11-12H,3,8,10H2,(H,24,25,27)/b4-2-;5-3-;4-3+;2*3-1-;2-1+
• InChIKey: IJIZTARAYDKVHW-OVARNUMPSA-N
• XLogP: 26.57
• TPSA: 496.30 Ų
• H-Bond Donors: 6
• H-Bond Acceptors: 40
• Rotatable Bonds: 9
• Heavy Atoms: 201
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2778.83
LogP ≤ 5	26.57
H-Bond Donors ≤ 5	6
H-Bond Acceptors ≤ 10	40

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'anil_di_alk_C(246)', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of (8E)-16-bromo-15-fluoro-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,8,13,15,17,21,23-nonaen-19-one;(9Z)-15-fluoro-16-(5-methyl-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-3-yl)-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13(18),14,16,21,23-nonaen-19-one;(9Z)-15-fluoro-16-morpholin-4-yl-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13,15,17,21,23-nonaen-19-one;(8E)-15-fluoro-16-(1-propylpyrazol-4-yl)-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,8,13(18),14,16,21,23-nonaen-19-one;(9Z)-15-fluoro-16-(1-propylpyrazol-4-yl)-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13(18),14,16,21,23-nonaen-19-one;(9Z)-15-fluoro-16-pyridin-4-yl-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13(18),14,16,21,23-nonaen-19-one?

The IUPAC name of (8E)-16-bromo-15-fluoro-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,8,13,15,17,21,23-nonaen-19-one;(9Z)-15-fluoro-16-(5-methyl-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-3-yl)-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13(18),14,16,21,23-nonaen-19-one;(9Z)-15-fluoro-16-morpholin-4-yl-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13,15,17,21,23-nonaen-19-one;(8E)-15-fluoro-16-(1-propylpyrazol-4-yl)-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,8,13(18),14,16,21,23-nonaen-19-one;(9Z)-15-fluoro-16-(1-propylpyrazol-4-yl)-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13(18),14,16,21,23-nonaen-19-one;(9Z)-15-fluoro-16-pyridin-4-yl-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13(18),14,16,21,23-nonaen-19-one (CID 158716369) is (8E)-16-bromo-15-fluoro-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,8,13,15,17,21,23-nonaen-19-one;(9Z)-15-fluoro-16-(5-methyl-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-3-yl)-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13(18),14,16,21,23-nonaen-19-one;(9Z)-15-fluoro-16-morpholin-4-yl-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13,15,17,21,23-nonaen-19-one;(8E)-15-fluoro-16-(1-propylpyrazol-4-yl)-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,8,13(18),14,16,21,23-nonaen-19-one;(9Z)-15-fluoro-16-(1-propylpyrazol-4-yl)-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13(18),14,16,21,23-nonaen-19-one;(9Z)-15-fluoro-16-pyridin-4-yl-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13(18),14,16,21,23-nonaen-19-one.

What is the SMILES notation for (8E)-16-bromo-15-fluoro-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,8,13,15,17,21,23-nonaen-19-one;(9Z)-15-fluoro-16-(5-methyl-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-3-yl)-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13(18),14,16,21,23-nonaen-19-one;(9Z)-15-fluoro-16-morpholin-4-yl-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13,15,17,21,23-nonaen-19-one;(8E)-15-fluoro-16-(1-propylpyrazol-4-yl)-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,8,13(18),14,16,21,23-nonaen-19-one;(9Z)-15-fluoro-16-(1-propylpyrazol-4-yl)-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13(18),14,16,21,23-nonaen-19-one;(9Z)-15-fluoro-16-pyridin-4-yl-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13(18),14,16,21,23-nonaen-19-one?

The canonical SMILES for (8E)-16-bromo-15-fluoro-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,8,13,15,17,21,23-nonaen-19-one;(9Z)-15-fluoro-16-(5-methyl-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-3-yl)-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13(18),14,16,21,23-nonaen-19-one;(9Z)-15-fluoro-16-morpholin-4-yl-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13,15,17,21,23-nonaen-19-one;(8E)-15-fluoro-16-(1-propylpyrazol-4-yl)-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,8,13(18),14,16,21,23-nonaen-19-one;(9Z)-15-fluoro-16-(1-propylpyrazol-4-yl)-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13(18),14,16,21,23-nonaen-19-one;(9Z)-15-fluoro-16-pyridin-4-yl-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13(18),14,16,21,23-nonaen-19-one is CCCn1cc(-c2cc3c(cc2F)OC/C=C\CCn2ccnc2-c2cccc(n2)NC3=O)cn1.CCCn1cc(-c2cc3c(cc2F)OCC/C=C/Cn2ccnc2-c2cccc(n2)NC3=O)cn1.CN1CCn2ncc(-c3cc4c(cc3F)OC/C=C\CCn3ccnc3-c3cccc(n3)NC4=O)c2C1.O=C1Nc2cccc(n2)-c2nccn2C/C=C/CCOc2cc(F)c(Br)cc21.O=C1Nc2cccc(n2)-c2nccn2CC/C=C\COc2cc(F)c(-c3ccncc3)cc21.O=C1Nc2cccc(n2)-c2nccn2CC/C=C\COc2cc(F)c(N3CCOCC3)cc21.

What is the InChIKey of (8E)-16-bromo-15-fluoro-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,8,13,15,17,21,23-nonaen-19-one;(9Z)-15-fluoro-16-(5-methyl-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-3-yl)-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13(18),14,16,21,23-nonaen-19-one;(9Z)-15-fluoro-16-morpholin-4-yl-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13,15,17,21,23-nonaen-19-one;(8E)-15-fluoro-16-(1-propylpyrazol-4-yl)-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,8,13(18),14,16,21,23-nonaen-19-one;(9Z)-15-fluoro-16-(1-propylpyrazol-4-yl)-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13(18),14,16,21,23-nonaen-19-one;(9Z)-15-fluoro-16-pyridin-4-yl-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13(18),14,16,21,23-nonaen-19-one?

The InChIKey is IJIZTARAYDKVHW-OVARNUMPSA-N. The full InChI is InChI=1S/C27H26FN7O2.2C26H25FN6O2.C25H20FN5O2.C24H24FN5O3.C20H16BrFN4O2/c1-33-11-12-35-23(17-33)20(16-30-35)18-14-19-24(15-21(18)28)37-13-4-2-3-9-34-10-8-29-26(34)22-6-5-7-25(31-22)32-27(19)36;2*1-2-10-33-17-18(16-29-33)19-14-20-23(15-21(19)27)35-13-5-3-4-11-32-12-9-28-25(32)22-7-6-8-24(30-22)31-26(20)34;26-20-16-22-19(15-18(20)17-7-9-27-10-8-17)25(32)30-23-6-4-5-21(29-23)24-28-11-13-31(24)12-2-1-3-14-33-22;25-18-16-21-17(15-20(18)29-10-13-32-14-11-29)24(31)28-22-6-4-5-19(27-22)23-26-7-9-30(23)8-2-1-3-12-33-21;21-14-11-13-17(12-15(14)22)28-10-3-1-2-8-26-9-7-23-19(26)16-5-4-6-18(24-16)25-20(13)27/h2,4-8,10,14-16H,3,9,11-13,17H2,1H3,(H,31,32,36);3,5-9,12,14-17H,2,4,10-11,13H2,1H3,(H,30,31,34);3-4,6-9,12,14-17H,2,5,10-11,13H2,1H3,(H,30,31,34);1,3-11,13,15-16H,2,12,14H2,(H,29,30,32);1,3-7,9,15-16H,2,8,10-14H2,(H,27,28,31);1-2,4-7,9,11-12H,3,8,10H2,(H,24,25,27)/b4-2-;5-3-;4-3+;2*3-1-;2-1+.

What are the key properties of (8E)-16-bromo-15-fluoro-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,8,13,15,17,21,23-nonaen-19-one;(9Z)-15-fluoro-16-(5-methyl-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-3-yl)-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13(18),14,16,21,23-nonaen-19-one;(9Z)-15-fluoro-16-morpholin-4-yl-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13,15,17,21,23-nonaen-19-one;(8E)-15-fluoro-16-(1-propylpyrazol-4-yl)-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,8,13(18),14,16,21,23-nonaen-19-one;(9Z)-15-fluoro-16-(1-propylpyrazol-4-yl)-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13(18),14,16,21,23-nonaen-19-one;(9Z)-15-fluoro-16-pyridin-4-yl-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13(18),14,16,21,23-nonaen-19-one?

(8E)-16-bromo-15-fluoro-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,8,13,15,17,21,23-nonaen-19-one;(9Z)-15-fluoro-16-(5-methyl-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-3-yl)-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13(18),14,16,21,23-nonaen-19-one;(9Z)-15-fluoro-16-morpholin-4-yl-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13,15,17,21,23-nonaen-19-one;(8E)-15-fluoro-16-(1-propylpyrazol-4-yl)-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,8,13(18),14,16,21,23-nonaen-19-one;(9Z)-15-fluoro-16-(1-propylpyrazol-4-yl)-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13(18),14,16,21,23-nonaen-19-one;(9Z)-15-fluoro-16-pyridin-4-yl-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13(18),14,16,21,23-nonaen-19-one has a molecular weight of 2778.83 g/mol, XLogP of 26.57, 9 rotatable bonds, 6 hydrogen bond donors, and 40 hydrogen bond acceptors.

Where does this data come from?

All data for (8E)-16-bromo-15-fluoro-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,8,13,15,17,21,23-nonaen-19-one;(9Z)-15-fluoro-16-(5-methyl-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-3-yl)-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13(18),14,16,21,23-nonaen-19-one;(9Z)-15-fluoro-16-morpholin-4-yl-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13,15,17,21,23-nonaen-19-one;(8E)-15-fluoro-16-(1-propylpyrazol-4-yl)-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,8,13(18),14,16,21,23-nonaen-19-one;(9Z)-15-fluoro-16-(1-propylpyrazol-4-yl)-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13(18),14,16,21,23-nonaen-19-one;(9Z)-15-fluoro-16-pyridin-4-yl-12-oxa-3,6,20,25-tetrazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,9,13(18),14,16,21,23-nonaen-19-one is sourced from PubChem (CID 158716369), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).